See also this year's filing and all EDGAR filings for this company.
PDF Report 0001436304_2013_Kythera_Biopharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'Provectus Biopharmaceuticals INC', 'shared_tokens': {'biopharmaceuticals'}}, {'other_company': 'Regenerx Biopharmaceuticals INC', 'shared_tokens': {'biopharmaceuticals'}}, {'other_company': 'Epirus Biopharmaceuticals Inc', 'shared_tokens': {'biopharmaceuticals'}}]} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001436304, Kythera Biopharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 87,589,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 275,000 |
| 3 | remainder_Assets | 8,358,000 |
| 4 | LiabilitiesCurrent | 16,222,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 11,094,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,505,000 |
| 9 | ResearchAndDevelopmentExpense | 43,184,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 16,890,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 96,222,000 |
| 1 | Liabilities | 27,316,000 |
| 2 | Expenses | 53,689,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 68,906,000 |
| 5 | NetIncome | -36,799,000 |
| 6 | ComprehensiveNetIncome | -36,799,000 |
| 7 | BaseVar | 97,058,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.84 |
| 9 | EconomicCapitalRatio | 2.91 |
Edgar->Model Mapping
Feature Distribution
